Navigation Links
Drug-coated balloon overcomes in-stent restenosis
Date:3/31/2008

CHICAGO, Ill. (March 31, 2008) An angioplasty balloon coated with a drug that reduces renarrowing of the coronary arteries appears to be more effective than a drug-eluting stent in treating an unwanted build-up of tissue inside a bare-metal coronary stent. After six months, the newly expanded artery remained more widely open within the stent after treatment with the paclitaxel-eluting balloon when compared to a paclitaxel-eluting stent, according to the Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease II-In-Stent Restenosis (PEPCAD II-ISR) study. Additional data suggested that at one year, rates of major cardiac events were also lower with the drug-coated balloon.

The PEPCAD II-ISR study is being reported today at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC).

This drug-eluting balloon clearly qualifies for consideration as an alternative to drug-eluting stents for the treatment of restenosis inside bare-metal stents, said Martin Unverdorben, MD, PhD, an associate professor of medicine at the University of Frankfurt/Main, Germany. However, two to three years more data are required before making a definitive statement.

In-stent restenosis remains a challenge, despite the availability of drug-eluting stents. Approximately 25 percent of patients treated with a bare-metal stent and about 10 percent of patients treated with a drug-eluting stent develop an overgrowth of vascular tissue and renarrowing inside the stent, or in-stent restenosis.

Treating in-stent restenosis with a drug-eluting stent is a complex procedure that adds another layer of metal to the artery and can create mechanical problems. The Sequent Please drug-eluting balloon ma
'/>"/>

Contact: Kathy Boyd David
pr@scai.org
717-422-1181
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Drug-Coated Balloons Keep Leg Arteries Open: Study
2. Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
3. Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
4. Study Finds Benefits With Drug-Coated Stents
5. Drug-Coated Stents Go Head to Head
6. Balloon catheter-based sinus surgery radiation exposure very low, safe
7. Balloon Valve May Be Alternative to Open-Heart Surgery
8. Sun Safety Awareness Reaches New Heights at Plano Hot Air Balloon Festival
9. Sun Safety Outreach to Families Takes Flight at the Plano Hot Air Balloon Festival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... For people who are keen on ... 2009-2019 Market Research Report would be an useful report ... on the present market scenario of this industry. The ... Chinese market of this industry. The report summarizes key ... the manufacturers in this industry. The report is a ...
(Date:5/24/2015)... 24, 2015 The federal court ... ) has scheduled its next monthly Case Management ... litigation. According to court documents filed in the ... Conference will be convened on June 2, 2015, ... Product Liability Litigation - MDL No. 2545) , ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... 23, 2015 Manufacturers are now required to ... (HSPF) of 8.2. Experts in the field agree that the ... , The HSPF score is what miles per gallon is ... the unit. Although the minimum HSPF score has been raised ... an HSPF score north of 12. Indeed, the regulation was ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
... Month, BETHESDA, Md., Jan. 3 AABB (formerly ... individuals,participating in the presidential elections to continue making an ... the month of,January, National Blood Donor Month (NBDM) provides ... give blood at a time of the year when,it ...
... ... Refractory Patients to Replace Current TIME-2 ... Trial ... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) today announced that the Tanespimycin in,Myeloma Evaluation or TIME-1 pivotal Phase ...
... young people,s blood sugar levels, study finds , THURSDAY, Jan. ... three nights running has the same negative effect on the ... pounds, diabetes researchers report. , In fact, young adults ... their risk of type 2 diabetes, according to a study ...
... others with a family history of ... glaucoma are particularly vulnerable, SAN FRANCISCO, Jan. 3 ... do not notice as their peripheral,vision diminishes or blind spots occur. ... disease are unaware of their condition.,January is Glaucoma Awareness Month, and ...
... Abbott (NYSE: ABT ),will announce its financial results ... on Wednesday, Jan. 23, 2008, before the market opens., ... webcast of the earnings,conference call at 8 a.m. Central ... Investor Relations Web site at, http://www.abbottinvestor.com . An archived ...
... the story is the same: New,Year,s resolutions made, New ... be combined with online health tools and expert advice,to ... growing health,properties on the Internet -- launched "Resolutions 2.0," ... video from Revolution Health at:, http://media.medialink.com/WebNR.aspx?story=34279 ) "Resolutions ...
Cached Medicine News:Health News:Exercise Your Right to Vote and Continue to Make a Difference by Giving Blood in 2008 2Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 2Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 3Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 4Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 5Health News:Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma 6Health News:Lack of Deep Sleep Raises Diabetes Risk 2Health News:Lack of Deep Sleep Raises Diabetes Risk 3Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 2Health News:Knowing Your Risks Can Stop the Sneak Thief of Sight 3Health News:VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches 'Resolutions 2.0' 2
(Date:5/22/2015)... , May 22, 2015  Amgen (NASDAQ: ... has commenced termination of its participation in ... AstraZeneca (LON:AZN, STO:AZN and NYSE: AZN ... in development for patients with moderate-to-severe plaque ... decision was based on events of suicidal ...
(Date:5/22/2015)... 22, 2015 /CNW/ - More than fifty years ago, Thalidomide ... sickness in expectant mothers. Tragically, Thalidomide caused serious and permanent ... Support has been provided to survivors over the ... Canada in 1991 and settlements from drug ... legal obligation to provide support, we have a clear moral ...
(Date:5/22/2015)... 22, 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ), ... hypothermic storage and cryopreservation freeze media ... tissues ("BioLife" or the "Company"), announced that the Company is ... The Company is scheduled to present at the ... at the Grand Hyatt Hotel in New York ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2
... Protectus Medical Devices, Inc. ("Protectus Medical Devices") ... medical devices, today named physician/surgeon Dr. Dan Hartley ... vast experience in research and development in pharmaceutical ... writing and regulatory compliance.  He has served as ...
... Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) ... accepted for review Optimer,s Marketing Authorization Application (MAA) for ... difficile infection (CDI) and for the prevention of ... announced the submission of its MAA for fidaxomicin to ...
Cached Medicine Technology:Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices 2Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices 3Optimer Pharmaceuticals' Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency 2Optimer Pharmaceuticals' Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency 3Optimer Pharmaceuticals' Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency 4
6" wide elastic belt transfers the apron weight off the shoulders to the hips making this apron the most comfortable for long procedures. Adjustable. Velcro keeps apron snug....
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
... NS272 is a fully featured Peripheral Nerve ... to monitor neuromuscular blocks during surgery or ... during regional anesthesia. , ,The constant ... only known PNS that can be programmed. ...
The NS242 is a base level constant current Conventional Peripheral Nerve Stimulator only. It uses conventional stimulation patterns only to monitor neuromuscular blocks i.e. Single Twitch, Train of F...
Medicine Products: